128 related articles for article (PubMed ID: 34788864)
1. Cancer risk in patients with immunoglobulin A nephropathy: a Swedish population-based cohort study.
Rehnberg J; Ludvigsson JF; Carrero JJ; Emilsson L
Nephrol Dial Transplant; 2022 Mar; 37(4):749-759. PubMed ID: 34788864
[TBL] [Abstract][Full Text] [Related]
2. Mortality in IgA Nephropathy: A Nationwide Population-Based Cohort Study.
Jarrick S; Lundberg S; Welander A; Carrero JJ; Höijer J; Bottai M; Ludvigsson JF
J Am Soc Nephrol; 2019 May; 30(5):866-876. PubMed ID: 30971457
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin A nephropathy and ischemic heart disease: a nationwide population-based cohort study.
Jarrick S; Lundberg S; Sundström J; Symreng A; Warnqvist A; Ludvigsson JF
BMC Nephrol; 2021 May; 22(1):165. PubMed ID: 33952193
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.
Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Bowel Disease Is More Common in Patients with IgA Nephropathy and Predicts Progression of ESKD: A Swedish Population-Based Cohort Study.
Rehnberg J; Symreng A; Ludvigsson JF; Emilsson L
J Am Soc Nephrol; 2021 Feb; 32(2):411-423. PubMed ID: 33177116
[TBL] [Abstract][Full Text] [Related]
6. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking may accelerate the progression of IgA nephropathy.
Wang S; Qin A; Pei G; Jiang Z; Dong L; Tan J; Tan L; Tang Y; Qin W
BMC Nephrol; 2021 Jun; 22(1):239. PubMed ID: 34187402
[TBL] [Abstract][Full Text] [Related]
8. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
[TBL] [Abstract][Full Text] [Related]
9. Kidney Failure Risk Prediction Equations in IgA Nephropathy: A Multicenter Risk Assessment Study in Chinese Patients.
Xie J; Lv J; Wang W; Li G; Liu Z; Chen H; Xu F; Sun J; Ouyang Y; Zhang X; Yang M; Shi M; Zhang W; Ren H; Kiryluk K; Zhang H; Chen N
Am J Kidney Dis; 2018 Sep; 72(3):371-380. PubMed ID: 29555434
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
11. Association between the progression of immunoglobulin A nephropathy and a controlled status of hypertension in the first year after diagnosis.
Oh TR; Choi HS; Oh SW; Oh J; Lee DW; Kim CS; Ma SK; Kim SW; Bae EH;
Korean J Intern Med; 2022 Jan; 37(1):146-153. PubMed ID: 32872745
[TBL] [Abstract][Full Text] [Related]
12. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study.
Yu GZ; Guo L; Dong JF; Shi SF; Liu LJ; Wang JW; Sui GL; Zhou XJ; Xing Y; Li HX; Lv JC; Zhang H
Am J Kidney Dis; 2020 Jul; 76(1):90-99. PubMed ID: 32197881
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy.
Donadio JV; Bergstralh EJ; Grande JP; Rademcher DM
Nephrol Dial Transplant; 2002 Jul; 17(7):1197-203. PubMed ID: 12105241
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of IgA nephropathy among individuals with celiac disease.
Welander A; Sundelin B; Fored M; Ludvigsson JF
J Clin Gastroenterol; 2013 Sep; 47(8):678-83. PubMed ID: 23442839
[TBL] [Abstract][Full Text] [Related]
15. Patient characteristics and outcomes by GN subtype in ESRD.
O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
[TBL] [Abstract][Full Text] [Related]
16. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study.
Sato Y; Tsukaguchi H; Higasa K; Kawata N; Inui K; Linh TNT; Quynh TTH; Yoshihiko I; Koiwa F; Yoshimura A
BMC Nephrol; 2021 Jun; 22(1):230. PubMed ID: 34147067
[TBL] [Abstract][Full Text] [Related]
17. Histopathologic features aid in predicting risk for progression of IgA nephropathy.
Walsh M; Sar A; Lee D; Yilmaz S; Benediktsson H; Manns B; Hemmelgarn B
Clin J Am Soc Nephrol; 2010 Mar; 5(3):425-30. PubMed ID: 20089495
[TBL] [Abstract][Full Text] [Related]
18. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy.
Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H
Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190
[TBL] [Abstract][Full Text] [Related]
19. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
[TBL] [Abstract][Full Text] [Related]
20. Association of obesity with the development of end stage renal disease in IgA nephropathy patients.
Wang S; Qin A; Dong L; Tan J; Zhou X; Qin W
Front Endocrinol (Lausanne); 2023; 14():1094534. PubMed ID: 37020590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
